EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Taurocholic acid promotes hepatic stellate cell activation via S1PR2/p38 MAPK/YAP signaling under cholestatic conditions

Jing Yang, Xujiao Tang, Zhu Liang, Mingzhu Chen, Lixin Sun

Clinical and Molecular Hepatology · 2023

DOI: 10.3350/cmh.2022.0327 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Molecular Hepatology, 2023. Verfasst von Jing Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences and Health Engineering, Jiangnan University, Wuxi, Jiangsu, China. Hauptthemen laut MEDLINE: Hepatic Stellate Cells, Cholestasis. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims: Disrupted bile acid regulation and accumulation in the liver can contribute to progressive liver damage and fibrosis. However, the effects of bile acids on the activation of hepatic stellate cells (HSCs) remain unclear. This study investigated the effects of bile acids on HSC activation during liver fibrosis, and examined the underlying mechanisms.

Methods

The immortalized HSCs, LX-2 and JS-1cells were used for the in vitro study. in vitro, the adeno-associated viruses adeno-associated virus-sh-S1PR2 and JTE-013 were used to pharmacologically inhibit the activity of S1PR2 in a murine model of fibrosis induced by a 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) diet. Histological and biochemical analyses were performed to study the involvement of S1PR2 in the regulation of fibrogenic factors as well as the activation properties of HSCs.

Results

S1PR2 was the predominant S1PR expressed in HSCs and was upregulated during taurocholic acid (TCA) stimulation and in cholestatic liver fibrosis mice. TCA-induced HSC proliferation, migration and contraction and extracellular matrix protein secretion were inhibited by JTE-013 and a specific shRNA targeting S1PR2 in LX-2 and JS-1 cells. Meanwhile, treatment with JTE-013 or S1PR2 deficiency significantly attenuated liver histopathological injury, collagen accumulation, and the expression of fibrogenesis-associated genes in mice fed a DDC diet. Furthermore, TCAmediated activation of HSCs through S1PR2 was closely related to the yes-associated protein (YAP) signaling pathway via p38 mitogen-activated protein kinase (p38 MAPK).

Conclusions

TCA-induced activation of the S1PR2/p38 MAPK/YAP signaling pathways plays a vital role in regulating HSC activation, which might be therapeutically relevant for targeting cholestatic liver fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatic Stellate CellsCholestasisMiceHumansAnimalsTaurocholic AcidLiverLiver CirrhosisFibrosisSphingosine-1-Phosphate Receptors

Stichwörter der Autor:innen

Hepatic stellate cellsLiver fibrosisSphingosine 1-phosphate receptor 2Taurocholic acidYes-associated protein

Substanzen

Taurocholic AcidS1PR2 protein, humanSphingosine-1-Phosphate Receptors

Autor:innen und Institutionen

  • School of Life Sciences and Health Engineering, Jiangnan University, Wuxi, Jiangsu, China.
  • Jiangsu Center Pharmacodynamic Research and Evaluation, China Pharmaceutical University, Nanjing, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yang, J., Tang, X., Liang, Z., Chen, M., & Sun, L. (2023). Taurocholic acid promotes hepatic stellate cell activation via S1PR2/p38 MAPK/YAP signaling under cholestatic conditions. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2022.0327

Vancouver

Yang J, Tang X, Liang Z, Chen M, Sun L. Taurocholic acid promotes hepatic stellate cell activation via S1PR2/p38 MAPK/YAP signaling under cholestatic conditions. Clinical and Molecular Hepatology. 2023. doi:10.3350/cmh.2022.0327

BibTeX
@article{Yang2023,
  author = {Yang, Jing and Tang, Xujiao and Liang, Zhu and Chen, Mingzhu and Sun, Lixin},
  title = {Taurocholic acid promotes hepatic stellate cell activation via S1PR2/p38 MAPK/YAP signaling under cholestatic conditions},
  journal = {Clinical and Molecular Hepatology},
  year = {2023},
  doi = {10.3350/cmh.2022.0327}
}
Kostenlos starten →